GI Dynamics announced encouraging new data regarding the EndoBarrier™to treat obesity and type 2 diabetes
Thursday, September 18th, 2008GI Dynamics, a clinical-stage medical device company pioneering the development of new approaches to treat metabolic disorders, announced new data(on 17th sept )regarding the EndoBarrier™, its unique, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes.
































